Ayrton Drug Manufacturing Ltd. announced unaudited earnings results for the third quarter ended March 31, 2017. For the quarter, the company reported revenue of GHS 27,113,709 against GHS 30,154,595 a year ago. Operating Profit was GHS 4,753,868 against GHS 4,521,633 a year ago. Profit before taxation was GHS 3,814,104 against GHS 2,717,135 a year ago. Profit for the period was GHS 3,120,794 against GHS 2,414,234 a year ago. Earnings per share were GHS 0.0145 against GHS 0.0112 a year ago. Net cash flow from operating activities were GHS 1,234,284 against GHS 1,798,744 a year ago. Cash used in purchase of property, plant and equipment was GHS 817,718 against GHS 475,317 a year ago.